Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2012-06-08
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of intraprostatic administration of
botulinum toxin Type A (BOTOX®) compared with placebo to treat urinary tract symptoms due to
benign prostatic hyperplasia.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA